Your session is about to expire
← Back to Search
Brain Health Assessment for Dementia (eRADAR Trial)
N/A
Waitlist Available
Led By Deborah Barnes, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after invitation mailed
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to make dementia detection easier and more affordable for primary care, to help those at risk get the care they need.
Who is the study for?
This trial is for individuals who have not been diagnosed with dementia and are not on any dementia medications. Participants must be active patients at a participating clinic and have enough data available to calculate what's called an eRADAR score. People currently in hospice care cannot join.
What is being tested?
The study is testing a new, cost-effective way to spot dementia early in primary care settings by using something called the Brain Health Assessment, which likely involves tests or questionnaires designed to evaluate memory and thinking skills.
What are the potential side effects?
Since this trial involves assessments rather than medication or invasive procedures, side effects are minimal but may include discomfort or stress during cognitive evaluations.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months after invitation mailed
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after invitation mailed
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
New dementia diagnosis
Secondary study objectives
New dementia diagnosis (secondary definitions)
New diagnosis of mild cognitive impairment
Number of dementia-related laboratory tests performed
+10 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Brain Health InterventionExperimental Treatment1 Intervention
Calculate eRADAR scores using EHR data to identify eligible individuals Invite eligible individuals for brain health assessment visit Enter results of brain health assessment visit into EHR Provide summary of results and recommended next steps to the Primary Care Physician and participant
Group II: Usual CareActive Control1 Intervention
Usual care Individuals who meet eligibility criteria will receive usual care.
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,591 Previous Clinical Trials
14,900,253 Total Patients Enrolled
Kaiser Permanente WashingtonUNKNOWN
2 Previous Clinical Trials
5,132 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,793 Previous Clinical Trials
28,190,767 Total Patients Enrolled
Deborah Barnes, PhDPrincipal InvestigatorUniversity of California, San Francisco
2 Previous Clinical Trials
3,630 Total Patients Enrolled
Sascha Dublin, MD, PhDPrincipal InvestigatorKP Washington Health Research Institute
2 Previous Clinical Trials
3,594 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently in hospice care.I have never been diagnosed with dementia nor am I on dementia medication.